BBHC
JUNO

Brown Brothers Harriman & Co’s Juno Therapeutics, Inc. JUNO Stock Holding History

Brown Brothers Harriman & Co’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-25
Closed -$1K – 1273
2017
Q4 		$1K Buy
+25
New +$1.25K ﹤0.01% 1168

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Brown Brothers Harriman & Co's JUNO Position: Q1 2018 in Review

Brown Brothers Harriman & Co sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 25 shares — an estimated $1K sold.

Brown Brothers Harriman & Co first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $1K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Brown Brothers Harriman & Co reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 25 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1K.
  • Brown Brothers Harriman & Co first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
  • Brown Brothers Harriman & Co's Juno Therapeutics, Inc. position peaked at $1K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2018, filed 14 May 2018.